PRAC meeting highlights 12 - 15 January 2026

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

Highlights from the December 2025 meeting are now available on the EMA website